Volagidemab (Anti-GCGR)
Volagidemab (Anti-GCGR) is an antagonistic monoclonal antibody (mAb) that targets glucagon receptor (GCGR). Volagidemab can be used in the research of type 1 diabetes (T1D). MW: 145.5 KD.
| Trivial name | REMD-477; AMG-477 |
| Catalog Number | A2487 |
| CAS# | 1233956-13-2 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/volagidemab-anti-gcgr.html |